期刊文献+

上海陆家嘴地区9家医疗联合体医院降糖药临床合理应用调查与分析 被引量:1

Investigation and Analysis of Clinical Rational Use of Antidiabetic Drugs in 9 Medical Union Hospitals from Shanghai Lujiazui District
原文传递
导出
摘要 目的:调查上海陆家嘴地区9家医疗联合体医院的降糖药处方,对药物利用情况及用药合理性进行分析。方法:采用回顾性调查方法,对9家医院2011年4月1-30日处方中降糖药用药频度(DDDs)、药物利用指数(DUI)、日均费用等进行药物利用度分析,同时调查处方的合理性。结果:降糖药处方共计15 843张,DDDs排前3位的是格列奇特、二甲双胍和预混胰岛素;处方出现频率最高的是阿卡波糖、二甲双胍、格列齐特;处方中单药使用率为77.95%,联合用药率为22.05%;DUI>1的有2种。降糖药在药物选择、用法用量、联合用药上存在不合理现象。结论:被调查医院降糖药应用基本合理,个别处方存在不合理,应引起临床医师的关注;同时药师在审核处方时应加强与医师的沟通,做好用药干预,提高合理用药水平。 OBJECTIVE: To investigate the prescription of antidiabetic drugs in 9 medical union hospitals from Shanghai Lujiazui District, and to evaluate utilization and rationality of drug use. METHODS: Using the cross-section research technique, the application of antidiabetic drugs in 9 hospitals in Apr. 2011 was analyzed in respects of DDDs, DUI, DDC, etc., the rationality of prescription was checked simultaneously. RESULTS: Among a total of 15 843 antidiabetic drugs prescriptions, top 3 drugs in the list of DDDs were glimepiride, metformin and premixed insulin; top 3 drugs in the list of fi'equency were acarbose, metformin and glimepiride. Single drug accounted for 77.95% in prescription, and drug combination accounted for 22.05%. DUI of 2 drugs was〉 1. It was irrational in fields of drug selection, usage and dosage, drug combination. CONCLUSIONS : The application of antidiabetic drugs is rational gener- ally, and some prescriptions are somehow unreasonable, which should arouse clinicians' concern; simultaneously, pharmacists should strengthen the communications with doctors, complete the medication intervention and improve the reasonable medication when they check prescriptions.
出处 《中国药房》 CAS CSCD 2014年第18期1638-1641,共4页 China Pharmacy
基金 紫禁城国际药师论坛2011糖尿病合理用药支持体系建设研究科研课题(No.CJP-1101-08)
关键词 降糖药 药物利用 合理用药 Antidiabetic drugs Drug utilization Rational drug use
  • 相关文献

参考文献4

二级参考文献30

  • 1中华人民共和国卫生部药政司.新药(西药)临床前研究指导原则汇编(药学药理学毒理学)[G].1993.
  • 2叶任高.内科学(第五版)[M].北京:人民卫生出版社,2001.398.
  • 3Thomas D, Miguel M. Update on insulin therapy for type 2 diabetes[J]. J Clin Endocrinol Metab, 2012, 97: 1405-1413.
  • 4Monnier L, Colette C, Dunseath GJ, et al. The loss of postprandial glycemic control precedes stepwise deterioration of fasting withworsening diabetes[J]. Diabetes Care, 2007, 30(2): 263-269.
  • 5Kikuchi K, Nezu U, Shirakawa J, et al. Correlations of fasting and postprandial blood glucose increments to the overall diurnal hyperglycemic status in type 2 diabetic patients: variations with levels of HbA [J]. Endocr J, 2010, 57: 259-266.
  • 6Yki-Jarvinen H, Kauppinen-Makelin R, Tiikkainen M, et al. Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study [J]. Diabetologia, 2006, 49(3): 442-451.
  • 7Allan V, SOrens L. Therapy of endocrine disease: insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues [J]. Eur J Endocrinol, 2012, 166: 159-170.
  • 8Beverley B, Soraya S, Celine L, et al. Are the same clinical risk factors relevant for incident diabetes defined by treatment, fasting plasma glucose, and HbA?[J]. Diabetes Care, 201 I, 34: 957-959.
  • 9David O, Carl T, Martin K. Insulin glargine plus oral antidiabetic agents in comparison with biphasic insulin in type 2 diabetes: a UK cost comparison[J]. The British Journal of Diabetes & Vascular Disease, 2011, 11: 141-144.
  • 10Nosheen l, Catherine M, Hisham M, et al. Improving patients' knowledge on the relationship between HbAt~ and mean plasma glucose improves glycaemic control among persons with poorly controlled diabetes[J]. Ann Clin Biochem. 2008, 45: 504-507.

共引文献8

同被引文献6

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部